25/06/2020 : Theradiag: Combined General Meeting of shareholders of June 25, 2020 on second call – Voting results and resolutions

Croissy-Beaubourg, June 25, 2020 6:00 pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, informs its shareholders that its Combined General Meeting was held on second call…

Continue Reading 25/06/2020 : Theradiag: Combined General Meeting of shareholders of June 25, 2020 on second call – Voting results and resolutions

Presentation Combined General Meeting of Shareholders on second call – June, 25th 2020

Theradiag will hold its General Meeting by conference call on Thursday, June 25 at 14:00 p.m.To participate, please dial +331.70.71.01.59 followed by the participant PIN code 92 21 52 68 #.The presentation is available above…

Continue Reading Presentation Combined General Meeting of Shareholders on second call – June, 25th 2020

08/06/2020 : Update on Covid-19 test activity and first Theradiag labeled tests CE marked

Croissy-Beaubourg, June 8, 8:15am CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today provides an update on its new Covid-19 test program launched in response to the…

Continue Reading 08/06/2020 : Update on Covid-19 test activity and first Theradiag labeled tests CE marked